GLYCERIN

N/A

Manufactured by Geri-Care Pharmaceuticals, Corp

16,949 FDA adverse event reports analyzed

Last updated: 2026-04-15

About GLYCERIN

GLYCERIN is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Geri-Care Pharmaceuticals, Corp. The most commonly reported adverse reactions for GLYCERIN include DRUG INEFFECTIVE, MACULAR DEGENERATION, PAIN, CONSTIPATION, OFF LABEL USE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for GLYCERIN.

Top Adverse Reactions

DRUG INEFFECTIVE792 reports
MACULAR DEGENERATION589 reports
PAIN526 reports
CONSTIPATION490 reports
OFF LABEL USE463 reports
NAUSEA445 reports
EYE PAIN403 reports
HEADACHE377 reports
PYREXIA356 reports
MALAISE337 reports
WEIGHT DECREASED333 reports
FALL296 reports
EYE IRRITATION280 reports
ABDOMINAL PAIN274 reports
ANAEMIA269 reports
DYSPNOEA250 reports
DIARRHOEA239 reports
HYPOTENSION235 reports
ERYTHEMA232 reports
FATIGUE226 reports
CHRONIC SINUSITIS225 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE224 reports
DYSPEPSIA216 reports
INFUSION RELATED REACTION215 reports
PARAESTHESIA ORAL213 reports
PROCEDURAL PAIN195 reports
BALANCE DISORDER191 reports
VISION BLURRED190 reports
DEPRESSED LEVEL OF CONSCIOUSNESS177 reports
VOMITING177 reports
COLITIS174 reports
PNEUMONIA172 reports
COGNITIVE DISORDER170 reports
MOBILITY DECREASED170 reports
HAEMATOCHEZIA169 reports
TOXICITY TO VARIOUS AGENTS168 reports
ORTHOSTATIC HYPOTENSION166 reports
DIZZINESS163 reports
BLOOD CALCIUM DECREASED162 reports
RECTAL HAEMORRHAGE162 reports
CREATININE RENAL CLEARANCE DECREASED160 reports
FREQUENT BOWEL MOVEMENTS160 reports
RADICULOPATHY156 reports
FEMALE GENITAL TRACT FISTULA155 reports
ORAL CANDIDIASIS155 reports
PROCTITIS155 reports
ASTHENIA154 reports
SEDATION154 reports
COLITIS ULCERATIVE152 reports
VAGINAL DISCHARGE152 reports
VAGINAL FLATULENCE152 reports
DEATH148 reports
SEDATION COMPLICATION148 reports
OCULAR HYPERAEMIA137 reports
DRY EYE127 reports
COUGH124 reports
ANXIETY117 reports
URINARY TRACT INFECTION116 reports
DECREASED APPETITE112 reports
RASH109 reports
PRODUCT DOSE OMISSION ISSUE107 reports
PRURITUS102 reports
LACRIMATION INCREASED96 reports
ACUTE KIDNEY INJURY95 reports
ARTHRALGIA95 reports
PRODUCT USE IN UNAPPROVED INDICATION93 reports
DRUG INTERACTION91 reports
BACK PAIN87 reports
CHEST PAIN87 reports
PHOTOPHOBIA87 reports
OVERDOSE84 reports
HYPERTENSION82 reports
INSOMNIA82 reports
PAIN IN EXTREMITY79 reports
EYE SWELLING78 reports
VISUAL IMPAIRMENT78 reports
DEHYDRATION77 reports
MUSCLE SPASMS75 reports
HAEMOGLOBIN DECREASED74 reports
CONDITION AGGRAVATED73 reports
FEBRILE NEUTROPENIA71 reports
PLATELET COUNT DECREASED70 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS70 reports
OCULAR DISCOMFORT69 reports
SOMNOLENCE68 reports
EMOTIONAL DISTRESS67 reports
THROMBOCYTOPENIA66 reports
FOREIGN BODY SENSATION IN EYES65 reports
BLOOD GLUCOSE INCREASED64 reports
PRODUCT USE COMPLAINT63 reports
GAIT DISTURBANCE62 reports
RENAL FUNCTION TEST ABNORMAL62 reports
NASOPHARYNGITIS61 reports
RESPIRATORY FAILURE61 reports
SEPSIS61 reports
DRUG HYPERSENSITIVITY60 reports
ABDOMINAL PAIN UPPER59 reports
HOSPITALISATION59 reports
WHITE BLOOD CELL COUNT DECREASED58 reports
DISEASE PROGRESSION57 reports

Report Outcomes

Out of 5,233 classified reports for GLYCERIN:

Serious 70.9%Non-Serious 29.1%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female3,303 (67.1%)
Male1,613 (32.8%)
Unknown7 (0.1%)

Reports by Age

Age 77221 reports
Age 71193 reports
Age 65144 reports
Age 69100 reports
Age 7490 reports
Age 6682 reports
Age 7082 reports
Age 7282 reports
Age 7382 reports
Age 7678 reports
Age 6174 reports
Age 6373 reports
Age 6773 reports
Age 6871 reports
Age 7871 reports
Age 6468 reports
Age 7966 reports
Age 7564 reports
Age 5763 reports
Age 5961 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with GLYCERIN?

This profile reflects 16,949 FDA FAERS reports that mention GLYCERIN. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for GLYCERIN?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, MACULAR DEGENERATION, PAIN, CONSTIPATION, OFF LABEL USE, NAUSEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures GLYCERIN?

Labeling and FAERS entries often list Geri-Care Pharmaceuticals, Corp in connection with GLYCERIN. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.